文献速递妇科

前瞻性IETA-4队列中超声评估肿瘤扩展及预测高风险子宫内膜癌策略的验证

Validation of ultrasound strategies to assess tumor extension and to predict high-risk endometrial cancer in women from the prospective IETA (International Endometrial Tumor Analysis)-4 cohort.
PubMed 文献 · Ultrasound Obstet Gynecol · 2019-12-13

基于前瞻性多中心IETA-4队列1538例子宫内膜癌患者,比较超声测量与主观超声评估(SA)预测深肌层浸润(MI)和宫颈间质浸润(CSI)的效能,并验证两种两步策略预测高风险癌。结果显示,在经验丰富的检查者手中,SA预测深MI和CSI优于超声测量,尤其对于Grade-1或-2肿瘤;SA联合活检分级与主观两步策略预测高风险癌的准确率均为80%。

要点

  • 在可测量病灶的1275例患者中,SA预测深MI的敏感度/特异度在Grade-1或-2肿瘤为70%/80%,在Grade-3或非子宫内膜样肿瘤为76%/64%。
  • SA预测CSI的敏感度/特异度在Grade-1或-2肿瘤为51%/94%,在Grade-3或非子宫内膜样肿瘤为50%/91%。
  • SA联合活检分级与主观两步策略预测高风险癌的准确率均为80%,客观两步策略为74%。

核心结论

  • 在经验丰富的超声检查者手中,SA预测子宫内膜癌深MI和CSI优于超声测量,尤其在Grade-1或-2肿瘤患者中。
  • 预测高风险癌的数学模型表现符合预期;预测高风险子宫内膜癌的最佳策略为SA联合活检分级和主观两步策略,两者准确率均为80%。

研究设计与样本

  • 研究为前瞻性多中心研究(IETA-4),纳入1538例子宫内膜癌患者,均接受标准化专家经阴道超声检查。
  • 以子宫切除标本的组织学评估为参考标准。

主要发现

  • 在1275例可测量病灶患者中,SA预测深MI的敏感度和特异度在Grade-1或-2子宫内膜样或黏液性肿瘤中为70%和80%,在Grade-3子宫内膜样或黏液性或非子宫内膜样肿瘤中为76%和64%。
  • SA预测CSI的敏感度和特异度在Grade-1或-2肿瘤中为51%和94%,在Grade-3或非子宫内膜样肿瘤中为50%和91%。
  • 肿瘤前后径和肿瘤/子宫前后径比值预测深MI的AUC分别为0.76和0.77,Dist-OCO预测CSI的AUC为0.72。
  • SA联合活检分级、主观两步策略和客观两步策略将患者正确分类为高风险癌的比例分别为80%、80%和74%。
  • 主观和客观模型应用于Grade-1和-2子宫内膜样肿瘤时AUC分别为0.76和0.75。

关键数值与推荐

  • 深MI预测:SA在Grade-1或-2肿瘤中敏感度70%、特异度80%,在Grade-3或非子宫内膜样肿瘤中敏感度76%、特异度64%。
  • CSI预测:SA在Grade-1或-2肿瘤中敏感度51%、特异度94%,在Grade-3或非子宫内膜样肿瘤中敏感度50%、特异度91%。
  • 超声测量预测深MI:肿瘤前后径AUC 0.76,肿瘤/子宫前后径比值AUC 0.77;预测CSI:Dist-OCO AUC 0.72。
  • 高风险癌预测准确率:SA联合活检分级80%,主观两步策略80%,客观两步策略74%。
  • 主观模型和客观模型用于Grade-1和-2子宫内膜样肿瘤的AUC分别为0.76和0.75。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compare the performance of ultrasound measurements and subjective ultrasound assessment (SA) in detecting deep myometrial invasion (MI) and cervical stromal invasion (CSI) in women with endometrial cancer, overall and according to whether they had low- or high-grade disease separately, and to validate published measurement cut-offs and prediction models to identify MI, CSI and high-risk disease (Grade-3 endometrioid or non-endometrioid cancer and/or deep MI and/or CSI). METHODS: The study comprised 1538 patients with endometrial cancer from the International Endometrial Tumor Analysis (IETA)-4 prospective multicenter study, who underwent standardized expert transvaginal ultrasound examination. SA and ultrasound measurements were used to predict deep MI and CSI. We assessed the diagnostic accuracy of the tumor/uterine anteroposterior (AP) diameter ratio for detecting deep MI and that of the distance from the lower margin of the tumor to the outer cervical os (Dist-OCO) for detecting CSI. We also validated two two-step strategies for the prediction of high-risk cancer; in the first step, biopsy-confirmed Grade-3 endometrioid or mucinous or non-endometrioid cancers were classified as high-risk cancer, while the second step encompassed the application of a mathematical model to classify the remaining tumors. The 'subjective prediction model' included biopsy grade (Grade 1 vs Grade 2) and subjective assessment of deep MI or CSI (presence or absence) as variables, while the 'objective prediction model' included biopsy grade (Grade 1 vs Grade 2) and minimal tumor-free margin. The predictive performance of the two two-step strategies was compared with that of simply classifying patients as high risk if either deep MI or CSI was suspected based on SA or if biopsy showed Grade-3 endometrioid or mucinous or non-endometrioid histotype (i.e. combining SA with biopsy grade). Histological assessment from hysterectomy was considered the reference standard. RESULTS: In 1275 patients with measurable lesions, the sensitivity and specificity of SA for detecting deep MI was 70% and 80%, respectively, in patients with a Grade-1 or -2 endometrioid or mucinous tumor vs 76% and 64% in patients with a Grade-3 endometrioid or mucinous or a non-endometrioid tumor. The corresponding values for the detection of CSI were 51% and 94% vs 50% and 91%. Tumor AP diameter and tumor/uterine AP diameter ratio showed the best performance for predicting deep MI (area under the receiver-operating characteristics curve (AUC) of 0.76 and 0.77, respectively), and Dist-OCO had the best performance for predicting CSI (AUC, 0.72). The proportion of patients classified correctly as having high-risk cancer was 80% when simply combining SA with biopsy grade vs 80% and 74% when using the subjective and objective two-step strategies, respectively. The subjective and objective models had an AUC of 0.76 and 0.75, respectively, when applied to Grade-1 and -2 endometrioid tumors. CONCLUSIONS: In the hands of experienced ultrasound examiners, SA was superior to ultrasound measurements for the prediction of deep MI and CSI of endometrial cancer, especially in patients with a Grade-1 or -2 tumor. The mathematical models for the prediction of high-risk cancer performed as expected. The best strategies for predicting high-risk endometrial cancer were combining SA with biopsy grade and the subjective two-step strategy, both having an accuracy of 80%. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Verbakel JY, Mascilini F, Wynants L, et al. Validation of ultrasound strategies to assess tumor extension and to predict high-risk endometrial cancer in women from the prospective IETA (International Endometrial Tumor Analysis)-4 cohort. Ultrasound Obstet Gynecol. 2019. PMID: 31225683. doi:10.1002/uog.20374

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。